Literature DB >> 26224579

Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.

Tsz-Lun Yeung1, Cecilia S Leung2, Kay-Pong Yip3, Chi Lam Au Yeung1, Stephen T C Wong4, Samuel C Mok5.   

Abstract

Ovarian cancer is the most lethal gynecological malignancy. It is usually diagnosed at a late stage, with a 5-yr survival rate of <30%. The majority of ovarian cancer cases are diagnosed after tumors have widely spread within the peritoneal cavity, limiting the effectiveness of debulking surgery and chemotherapy. Owing to a substantially lower survival rate at late stages of disease than at earlier stages, the major cause of ovarian cancer deaths is believed to be therapy-resistant metastasis. Although metastasis plays a crucial role in promoting ovarian tumor progression and decreasing patient survival rates, the underlying mechanisms of ovarian cancer spread have yet to be thoroughly explored. For many years, researchers have believed that ovarian cancer metastasizes via a passive mechanism by which ovarian cancer cells are shed from the primary tumor and carried by the physiological movement of peritoneal fluid to the peritoneum and omentum. However, the recent discovery of hematogenous metastasis of ovarian cancer to the omentum via circulating tumor cells instigated rethinking of the mode of ovarian cancer metastasis and the importance of the "seed-and-soil" hypothesis for ovarian cancer metastasis. In this review we discuss the possible mechanisms by which ovarian cancer cells metastasize from the primary tumor to the omentum, the cross-talk signaling events between ovarian cancer cells and various stromal cells that play crucial roles in ovarian cancer metastasis, and the possible clinical implications of these findings in the management of this deadly, highly metastatic disease.

Entities:  

Keywords:  hematogenous metastasis; metastasis; ovarian cancer; passive dissemination; stromal-tumoral interaction

Mesh:

Year:  2015        PMID: 26224579      PMCID: PMC4593771          DOI: 10.1152/ajpcell.00188.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  170 in total

Review 1.  Pazopanib: Clinical development of a potent anti-angiogenic drug.

Authors:  Fabio A B Schutz; Toni K Choueiri; Cora N Sternberg
Journal:  Crit Rev Oncol Hematol       Date:  2010-04-24       Impact factor: 6.312

Review 2.  Tumor interactions with the vasculature: angiogenesis and tumor metastasis.

Authors:  C H Blood; B R Zetter
Journal:  Biochim Biophys Acta       Date:  1990-06-01

3.  Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma.

Authors:  Shusaku Ohira; Motoko Sasaki; Kenichi Harada; Yasunori Sato; Yoh Zen; Kumiko Isse; Kazuto Kozaka; Akira Ishikawa; Koji Oda; Yuji Nimura; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

Review 4.  Unraveling the obesity and breast cancer links: a role for cancer-associated adipocytes?

Authors:  Bé Atrice Dirat; Ludivine Bochet; Ghislaine Escourrou; Philippe Valet; Catherine Muller
Journal:  Endocr Dev       Date:  2010-06-15

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  Differential gene expression in ovarian carcinoma: identification of potential biomarkers.

Authors:  Kathleen Hibbs; Keith M Skubitz; Stefan E Pambuccian; Rachael C Casey; Kathryn M Burleson; Theodore R Oegema; Jeannine J Thiele; Suzanne M Grindle; Robin L Bliss; Amy P N Skubitz
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 7.  Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis.

Authors:  Hilary A Kenny; Songuel Dogan; Marion Zillhardt; Anirban K Mitra; S Diane Yamada; Thomas Krausz; Ernst Lengyel
Journal:  Cancer Treat Res       Date:  2009

8.  Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts.

Authors:  D Tarin; J E Price; M G Kettlewell; R G Souter; A C Vass; B Crossley
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

9.  Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.

Authors:  A Kraft; K Weindel; A Ochs; C Marth; J Zmija; P Schumacher; C Unger; D Marmé; G Gastl
Journal:  Cancer       Date:  1999-01-01       Impact factor: 6.860

10.  Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.

Authors:  Calvin Tebbe; Jasdeep Chhina; Sajad A Dar; Kalli Sarigiannis; Shailendra Giri; Adnan R Munkarah; Ramandeep Rattan
Journal:  Oncotarget       Date:  2014-07-15
View more
  120 in total

Review 1.  Role of Forkhead Box Class O proteins in cancer progression and metastasis.

Authors:  Chang Geun Kim; Hyemin Lee; Nehal Gupta; Sharavan Ramachandran; Itishree Kaushik; Sangeeta Srivastava; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Semin Cancer Biol       Date:  2017-08-01       Impact factor: 15.707

2.  Cell and Molecular Processes in Cancer Metastasis: an AJP-Cell Physiology set of Themed Reviews.

Authors:  Josephine C Adams; Thordur Oskarsson
Journal:  Am J Physiol Cell Physiol       Date:  2015-10-01       Impact factor: 4.249

3.  Prognostic significance of discoidin domain receptor 2 (DDR2) expression in ovarian cancer.

Authors:  Yi Fan; Zhe Xu; Jin Fan; Liu Huang; Ming Ye; Kun Shi; Zheng Huang; Yaqiong Liu; Langchi He; Jiezhen Huang; Yibin Wang; Qiufeng Li
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

4.  Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis.

Authors:  Hilary A Kenny; Madhu Lal-Nag; Min Shen; Betul Kara; Dominik A Nahotko; Kristen Wroblewski; Sarah Fazal; Siquan Chen; Chun-Yi Chiang; Yen-Ju Chen; Kyle R Brimacombe; Juan Marugan; Marc Ferrer; Ernst Lengyel
Journal:  Mol Cancer Ther       Date:  2019-09-27       Impact factor: 6.261

5.  High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma.

Authors:  Kai Lu; Feiling Feng; Yingcheng Yang; Kai Liu; Jicheng Duan; Hu Liu; Jiahe Yang; Mengchao Wu; Chen Liu; Yanxin Chang
Journal:  J Gastroenterol       Date:  2019-09-27       Impact factor: 7.527

Review 6.  Liquid Biopsy in the Clinical Management of High-Grade Serous Epithelial Ovarian Cancer-Current Use and Future Opportunities.

Authors:  Lara Paracchini; Maurizio D'Incalci; Sergio Marchini
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

7.  Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.

Authors:  Cecilia S Leung; Tsz-Lun Yeung; Kay-Pong Yip; Kwong-Kwok Wong; Samuel Y Ho; Lingegowda S Mangala; Anil K Sood; Gabriel Lopez-Berestein; Jianting Sheng; Stephen Tc Wong; Michael J Birrer; Samuel C Mok
Journal:  J Clin Invest       Date:  2017-12-18       Impact factor: 14.808

8.  Overexpression of TRIM24 is correlated with the progression of human cervical cancer.

Authors:  Li Lin; Weihua Zhao; Bo Sun; Xinyu Wang; Qiao Liu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

9.  EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment.

Authors:  Xinlu Wang; Minying Zheng; Fei Fei; Chunyuan Li; Jiaxing Du; Kai Liu; Yuwei Li; Shiwu Zhang
Journal:  Med Oncol       Date:  2019-08-12       Impact factor: 3.064

10.  Detachment from the primary site and suspension in ascites as the initial step in metabolic reprogramming and metastasis to the omentum in ovarian cancer.

Authors:  Masakazu Sato; Kei Kawana; Katsuyuki Adachi; Asaha Fujimoto; Mitsuyo Yoshida; Hiroe Nakamura; Haruka Nishida; Tomoko Inoue; Ayumi Taguchi; Juri Ogishima; Satoko Eguchi; Aki Yamashita; Kensuke Tomio; Atsushi Komatsu; Osamu Wada-Hiraike; Katsutoshi Oda; Takeshi Nagamatsu; Yutaka Osuga; Tomoyuki Fujii
Journal:  Oncol Lett       Date:  2017-11-09       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.